{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:10:13Z","timestamp":1758125413995},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.neulet.2009.05.048","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T09:09:18Z","timestamp":1242896958000},"page":"87-91","source":"Crossref","is-referenced-by-count":15,"title":["Vitreous growth hormone and visual dysfunction"],"prefix":"10.1016","volume":"460","author":[{"given":"Misagh","family":"Ziaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Tennant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmond J.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2009.05.048_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jpeds.2005.08.050","article-title":"Endocrinological and auxological abnormalities in young children with optic nerve hypoplasia: a prospective study","volume":"148","author":"Ahmad","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.neulet.2009.05.048_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-8993(93)90014-E","article-title":"Growth hormone increases somatostatin release and messenger ribonucleic acid levels in the rat hypothalamus","volume":"623","author":"Aguila","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2009.05.048_bib3","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1210\/en.2003-0651","article-title":"Retinal growth hormone in the chick embryo","volume":"144","author":"Baudet","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.neulet.2009.05.048_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000267221","article-title":"Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy","volume":"25","author":"Baudouin","year":"1993","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.neulet.2009.05.048_bib5","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1167\/iovs.06-0057","article-title":"Comparative effects of early postnatal ibuprofen and indomethacin on VEGF, IGF-1, and GH during rat ocular development","volume":"47","author":"Beharry","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neulet.2009.05.048_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000098503","article-title":"Use of long-acting somatostatin analogue treatment in diabetic retinopathy","volume":"39","author":"Boehm","year":"2007","journal-title":"Dev. Ophthalmol."},{"key":"10.1016\/j.neulet.2009.05.048_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/bjo.81.3.228","article-title":"Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management","volume":"81","author":"Boulton","year":"1997","journal-title":"Brit. J. Ophthalmol."},{"key":"10.1016\/j.neulet.2009.05.048_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2337\/diacare.23.1.80","article-title":"Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case\u2013control study","volume":"23","author":"Burgos","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neulet.2009.05.048_bib9","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.2337\/dc07-0332","article-title":"Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration","volume":"30","author":"Carrasco","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neulet.2009.05.048_bib10","first-page":"337","article-title":"Blood-retinal barriers in health and disease","volume":"100","author":"Cunha-Vaz","year":"1980","journal-title":"Trans. Ophthalmol. Soc. UK"},{"key":"10.1016\/j.neulet.2009.05.048_bib11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0014-4835(03)00213-6","article-title":"The blood retinal barriers system. Basic concepts and clinical evaluation","volume":"78","author":"Cunha-Vaz","year":"2004","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.neulet.2009.05.048_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/s-2005-861362","article-title":"The growth hormone hypothesis \u2013 2005 revision","volume":"37","author":"Frystyk","year":"2005","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.neulet.2009.05.048_bib13","first-page":"94","article-title":"Somatopause reflects age-related changes in the neural control of GH\/IGF-I axis","volume":"28","author":"Giordano","year":"2005","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.neulet.2009.05.048_bib14","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.2337\/diabetes.53.9.2428","article-title":"Changes in IGF activities in human diabetic vitreous","volume":"53","author":"Guidry","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.neulet.2009.05.048_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1385\/JMN:28:3:257","article-title":"Retinal growth hormone in perinatal and adult rats","volume":"28","author":"Harvey","year":"2006","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neulet.2009.05.048_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1139\/y03-034","article-title":"Growth hormone in the nervous system: autocrine or paracrine roles in retinal function?","volume":"81","author":"Harvey","year":"2003","journal-title":"Can. J. Physiol. Pharm."},{"key":"10.1016\/j.neulet.2009.05.048_bib17","first-page":"510","article-title":"Growth hormone and developmental ocular function: clinical and basic studies","volume":"5","author":"Harvey","year":"2007","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.neulet.2009.05.048_bib18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ygcen.2006.12.024","article-title":"Growth hormone in the visual system: comparative endocrinology","volume":"153","author":"Harvey","year":"2007","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.neulet.2009.05.048_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neulet.2009.03.073","article-title":"Growth hormone is present in the human retina and vitreous fluid","volume":"455","author":"Harvey","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2009.05.048_bib20","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1210\/jc.84.2.795","article-title":"Reduced retinal vascularization in children with growth hormone deficiency","volume":"84","author":"Hellstorm","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neulet.2009.05.048_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/00365515909060410","article-title":"A method for determination of hemoglobin in plasma by near-ultraviolet spectrophostometry","volume":"11","author":"Harobe","year":"1959","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.neulet.2009.05.048_bib22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1076\/ceyr.23.5.368.5441","article-title":"Vitreous levels of insulin-like growth factor-1 in patients with proliferative diabetic retinopathy","volume":"23","author":"Inokuchi","year":"2001","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.neulet.2009.05.048_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1507\/endocrj1954.30.7","article-title":"Optic hypoplasia with pituitary dwarfism (Kaplan\u2013Grumbach\u2013Hoyt syndrome, or DeMorsier Syndrome)","volume":"30","author":"Ishihara","year":"1983","journal-title":"Endocrinol. Japon."},{"key":"10.1016\/j.neulet.2009.05.048_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/bjo.67.2.80","article-title":"Fate of insulin in the retina: an autoradiographic study","volume":"67","author":"James","year":"1983","journal-title":"Brit. J. Ophthalmol."},{"key":"10.1016\/j.neulet.2009.05.048_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1076\/ceyr.28.1.47.23487","article-title":"Diabetes has an additive effect on neural apoptosis in rat retina with chronically elevated intraocular pressure","volume":"28","author":"Kanamori","year":"2004","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.neulet.2009.05.048_bib26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0950-351X(97)80257-1","article-title":"Growth hormone secretion in the elderly: ageing and the somatopause","volume":"11","author":"Martin","year":"1997","journal-title":"Bailliere Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neulet.2009.05.048_bib27","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1167\/iovs.05-1046","article-title":"Ontogeny of VEGF, IGF-1, and GH in neonatal rat serum, vitreous fluid, and retina from birth to weaning","volume":"47","author":"Modanlou","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neulet.2009.05.048_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000081775","article-title":"Diabetes mellitus as a risk factor for glaucomatous optic neuropathy","volume":"219","author":"Nakamura","year":"2005","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.neulet.2009.05.048_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF02581388","article-title":"Somatomedin-C (SM-C). Study in diabetic patients with and without retinopathy","volume":"26","author":"Nardelli","year":"1989","journal-title":"Acta Diabetol. Lat."},{"key":"10.1016\/j.neulet.2009.05.048_bib30","first-page":"2667","article-title":"Endocrine disorders associated with impaired glucose tolerance","volume":"54","author":"Ogino","year":"1996","journal-title":"Nippon Rinsho"},{"key":"10.1016\/j.neulet.2009.05.048_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neulet.2005.07.057","article-title":"Diabetes: a potential enhancer of retinal injury in rat retinas","volume":"390","author":"Oshitari","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2009.05.048_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0925-4773(02)00188-0","article-title":"Persistent neurogenesis in the teleost retina: evidence for regulation by the growth-hormone\/insulin-like growth factor-1 axis","volume":"117","author":"Otteson","year":"2002","journal-title":"Mech. Dev."},{"key":"10.1016\/j.neulet.2009.05.048_bib33","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.2337\/diab.46.2.S26","article-title":"Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown","volume":"46","author":"Pfeiffer","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.neulet.2009.05.048_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000180771","article-title":"Suppression of growth hormone and somatomedin C by long-acting somatostatin analog SMS 201-995 in type I diabetes mellitus","volume":"27","author":"Plewe","year":"1987","journal-title":"Horm. Res."},{"key":"10.1016\/j.neulet.2009.05.048_bib35","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1073\/pnas.88.2.617","article-title":"Human growth hormone stimulates proliferation of human retinal microvascular endothelial cells in vitro","volume":"88","author":"Rymaszewski","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2009.05.048_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00429-004-0422-1","article-title":"Growth hormone as an early embryonic growth and differentiation factor","volume":"209","author":"Sanders","year":"2004","journal-title":"Anat. Embryol. (Berl.)"},{"key":"10.1016\/j.neulet.2009.05.048_bib37","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.exer.2005.03.013","article-title":"Retinal growth hormone is an anti-apoptotic factor in embryonic retinal ganglion cell differentiation","volume":"81","author":"Sanders","year":"2005","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.neulet.2009.05.048_bib38","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.exer.2006.06.009","article-title":"Retinal ganglion cell survival in development: mechanisms of retinal growth hormone action","volume":"83","author":"Sanders","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.neulet.2009.05.048_bib39","first-page":"920","article-title":"Endogenous GH in human retinal ganglion cells correlates with cell survival","volume":"15","author":"Sanders","year":"2009","journal-title":"Mol. Vision."},{"key":"10.1016\/j.neulet.2009.05.048_bib40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1042\/CS20020278","article-title":"Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case\u2013control study","volume":"104","author":"Simo","year":"2003","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.neulet.2009.05.048_bib41","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0002-9394(02)01538-6","article-title":"Free insulin growth factor-1 and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy","volume":"134","author":"Simo","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.neulet.2009.05.048_bib42","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.2337\/diacare.25.12.2282","article-title":"Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy","volume":"25","author":"Simo","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neulet.2009.05.048_bib43","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1464-5491.2004.01208.x","article-title":"Medical management of diabetic retinopathy","volume":"21","author":"Sjolie","year":"2004","journal-title":"Diabet. Med."},{"key":"10.1016\/j.neulet.2009.05.048_bib44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-2007-978621","article-title":"Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II, and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy","volume":"32","author":"Spranger","year":"2000","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.neulet.2009.05.048_bib45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-2001-15283","article-title":"Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?","volume":"33","author":"Spranger","year":"2001","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.neulet.2009.05.048_bib46","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1126\/science.276.5319.1706","article-title":"Essential role of growth hormone in ischemia-induced retinal neovascularization","volume":"276","author":"Smith","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neulet.2009.05.048_bib47","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.2174\/092986706778773086","article-title":"The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy","volume":"13","author":"Wilkinson-Berka","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neulet.2009.05.048_bib48","first-page":"1529","article-title":"An antisense oligonucleotide targeting the growth hormone receptor inhibits neovascularization in a mouse model of retinopathy","volume":"13","author":"Wilkinson-Berka","year":"2007","journal-title":"Mol. Vis."},{"key":"10.1016\/j.neulet.2009.05.048_bib49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF01959475","article-title":"Growth hormone deficiency of hypothalamic origin in septo-optic dysplasia","volume":"150","author":"Yukizane","year":"1990","journal-title":"Eur. J. Pediatr."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394009006727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394009006727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T13:22:45Z","timestamp":1545225765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394009006727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0304394009006727"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2009.05.048","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}